Dr. Martens plc
DOCMF · OTC
9/30/2025 | 3/31/2025 | 3/30/2025 | 9/30/2024 | |
|---|---|---|---|---|
| Revenue | $432,832 | – | $463,000 | $324,600 |
| % Growth | – | – | 42.6% | – |
| Cost of Goods Sold | $196,656 | – | $159,000 | $116,900 |
| Gross Profit | $236,176 | – | $304,000 | $207,700 |
| % Margin | 54.6% | – | 65.7% | 64% |
| R&D Expenses | $0 | – | $0 | $0 |
| G&A Expenses | $0 | – | $0 | $0 |
| SG&A Expenses | $231,740 | – | $155,600 | $222,800 |
| Sales & Mktg Exp. | $0 | – | $0 | $0 |
| Other Operating Expenses | $0 | – | $77,200 | $0 |
| Operating Expenses | $231,740 | – | $232,800 | $222,800 |
| Operating Income | $4,436 | – | $71,200 | -$15,100 |
| % Margin | 1% | – | 15.4% | -4.7% |
| Other Income/Exp. Net | -$19,222 | – | -$33,700 | -$13,600 |
| Pre-Tax Income | -$14,786 | – | $37,500 | -$28,700 |
| Tax Expense | -$1,344 | – | $12,200 | -$7,900 |
| Net Income | -$13,442 | – | $25,300 | -$20,800 |
| % Margin | -3.1% | – | 5.5% | -6.4% |
| EPS | -0.014 | – | 0.034 | -0.022 |
| % Growth | – | – | 254.5% | – |
| EPS Diluted | -0.014 | – | 0.034 | -0.022 |
| Weighted Avg Shares Out | 965,666 | – | 961,772 | 945,455 |
| Weighted Avg Shares Out Dil | 965,666 | – | 963,847 | 945,455 |
| Supplemental Information | – | – | – | – |
| Interest Income | $2,285 | – | $2,712 | $0 |
| Interest Expense | $18,953 | – | $21,439 | $13,500 |
| Depreciation & Amortization | $46,509 | – | $61,900 | $10,600 |
| EBITDA | $50,676 | – | $115,000 | -$4,500 |
| % Margin | 11.7% | – | 24.8% | -1.4% |